Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Company Profiles Market

Company Profiles News

Company Profiles Stocks

Company Profiles Market
Company Profiles News
Company Profiles Stocks

Seelos Therapeutics Inc.

NASDAQ:SEEL

Featured Articles and Interviews

More Featured Articles and Inverviews

Press Releases

May 16, 2024

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Dec 04, 2019

Seelos Therapeutics Gets Notice of Allowance for Another US Patent for SLS-005

Nov 27, 2019

Seelos Therapeutics Begins Dosing in Phase 1 PK/KD Study

More Press Releases

Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in the Central Nervous System ("CNS") disorders and other rare disorders.

Go Deeper

AI Powered

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch in 2025

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.